![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, September 09, 2019 12:01:35 PM
Real numbers --- Nivida trades at 9x sales and it is growing sales at like 20%/year. Sona is much smaller and is growing sales at 100%/year.
Even if we were to trade at NVDA's multiple we would be at a 9x15M (sales) which is 135M Market cap, or about 5.5x higher than where we are here, which is roughly 77 cents.
Of course, most investors would give Sona a far higher multiple because of its small size and fast sales growth pace. No reason this wouldnt trade at 15-20x sales which of course would be 1.50+.
Of note, this is the OTC and there are about 7 of us here that are retailers, the rest are insiders that buy and hold and not few others know about this, so this wont trade at a normal valuation until this moves to a higher exchange IMO and/or gets some legit big money accredited investors involved.
We are currently trading at 1.8x sales.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM